Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials,...
FDA Recall #D-0008-2026 — Class II — September 26, 2025
Product Description
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Reason for Recall
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Recalling Firm
Dr. Reddy's Laboratories, Inc. — Princeton, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
571 vials
Distribution
Nationwide within the USA.
Code Information
Lot # K250048
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated